Short- and long-term efficacy and safety of flecainide acetate for supraventricular arrhythmias
- 20 August 1992
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 70 (5), A3-A10
- https://doi.org/10.1016/0002-9149(92)91071-b
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Catheter Ablation of Accessory Atrioventricular Pathways (Wolff–Parkinson–White Syndrome) by Radiofrequency CurrentNew England Journal of Medicine, 1991
- Mortality and Morbidity in Patients Receiving Encainide, Flecainide, or PlaceboNew England Journal of Medicine, 1991
- Flecainide acetate treatment of paroxysmal supraventricular tachycardia and paroxysmal atrial fibrillation: Dose-response studiesJournal of the American College of Cardiology, 1991
- Prevention of symptomatic recurrences of paroxysmal atrial fibrillation in patients initially tolerating antiarrhythmic therapy. A multicenter, double-blind, crossover study of flecainide and placebo with transtelephonic monitoring. Flecainide Supraventricular Tachycardia Study Group.Circulation, 1989
- Ablation of a Left‐Sided Free‐Wall Accessory Pathway by Percutaneous Catheter Application of Radiofrequency Current in a Patient with the Wolff‐Parkinson‐White SyndromePacing and Clinical Electrophysiology, 1989
- Summary of efficacy and safety of flecainide for supraventricular arrhythmiasThe American Journal of Cardiology, 1988
- High frequency alternating current ablation of an accessory pathway in humansJournal of the American College of Cardiology, 1987
- Implanted Atrial Pacemakers for Paroxysmal Atrial FlutterAnnals of Internal Medicine, 1987
- The status of surgery for cardiac arrhythmias.Circulation, 1985
- Atrial Flutter, Atrial Fibrillation, and Other Primary Atrial TachycardiasMedical Clinics of North America, 1984